NPPA issued a notification regarding the fixation of the retail price of Levosalbutamol Sulphate eq. to Levosalbutamol 1.25 mg + Ipratropium Bromide eq. to Ipratropium (Anhydrous) 500 mcg

Aug 01, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on July 31, 2024, issued a notification regarding the fixation of the retail price of Levosalbutamol Sulphate eq. to Levosalbutamol 1.25 mg + Ipratropium Bromide eq. to Ipratropium (Anhydrous) 500 mcg.

The following has been stated: -

•Each 2.5 ml Contains Levosalbutamol Sulphate eq. to Levosalbutamol 1.25 mg + Ipratropium Bromide eq. to Ipratropium (Anhydrous) 500 mcg for M/s. Axa Parenterals Ltd. (Manufacturer) & M/s Workcell Solutions Pvt. Ltd. (Marketer) and the retail price is 5.75 (Rs.)

[Notification No. 19(4031)/2024/2024/DP/NPPA/DIV.III/8597/2024]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT